FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221006100> ?p ?o ?g. }

• W4221006100 endingPage "730" @default.
• W4221006100 startingPage "721" @default.
• W4221006100 abstract "The robust enrollment in SPARTAN and SAMURAI provided the opportunity to present post-hoc descriptive details on migraine disease characteristics and treatment outcomes after treatment with lasmiditan, a selective serotonin (5-HT1F) receptor agonist, in racial and ethnic subgroups.Descriptive data from racial (White [W](n = 3471) and Black or African American [AA](n = 792)) and ethnic (Hispanic or Latinx [HL](n = 775) and Non-Hispanic or Latinx [Non-HL](n = 3637)) populations are presented on pooled data from two double-blind, placebo-controlled, randomized Phase 3 studies (SAMURAI [NCT02439320] and SPARTAN [NCT2605174]). Patients were treated with lasmiditan (50 (SPARTAN only), 100, or 200 mg) or placebo for a single migraine attack of moderate-to-severe intensity. Efficacy data were recorded in an electronic diary at baseline, 30, 60, 90, and 120 min. Safety was evaluated and reported by occurrences of adverse events.Clinical characteristics were generally similar across populations. W participants had longer migraine history than AA participants, and Non-HL participants had more migraine disability than HL participants. In the lasmiditan single-attack studies, AA participants waited longer than W participants to take study drug. A higher proportion of HL participants rated baseline migraine severity as severe compared to Non-HL participants. Response to lasmiditan was similar across racial and ethnic groups, including pain response, freedom from most bothersome symptom and migraine-related disability, and safety and tolerability. Across multiple outcomes, AA and HL participants tended to report more positive outcomes.There were few differences in demographic and clinical characteristics across racial and ethnic groups. Similar lasmiditan efficacy and safety outcomes were observed in AA versus W participants, and in HL versus Non-HL participants. Small observed differences may be driven by a tendency toward a more positive response observed across all treatment groups by AA and HL participants." @default.
• W4221006100 created "2022-04-03" @default.
• W4221006100 creator A5012905064 @default.
• W4221006100 creator A5019197879 @default.
• W4221006100 creator A5039298409 @default.
• W4221006100 creator A5054051543 @default.
• W4221006100 creator A5089812265 @default.
• W4221006100 date "2022-04-03" @default.
• W4221006100 modified "2023-09-27" @default.
• W4221006100 title "Migraine history and response to lasmiditan across racial and ethnic groups" @default.
• W4221006100 cites W1527975395 @default.
• W4221006100 cites W1980229633 @default.
• W4221006100 cites W1987570957 @default.
• W4221006100 cites W1998215755 @default.
• W4221006100 cites W2007658526 @default.
• W4221006100 cites W2025006950 @default.
• W4221006100 cites W2038748095 @default.
• W4221006100 cites W2052820002 @default.
• W4221006100 cites W2078402149 @default.
• W4221006100 cites W2079138174 @default.
• W4221006100 cites W2104107693 @default.
• W4221006100 cites W2111169381 @default.
• W4221006100 cites W2116400683 @default.
• W4221006100 cites W2125197474 @default.
• W4221006100 cites W2131935280 @default.
• W4221006100 cites W2149133494 @default.
• W4221006100 cites W2168536722 @default.
• W4221006100 cites W2270371209 @default.
• W4221006100 cites W2343778584 @default.
• W4221006100 cites W2416895451 @default.
• W4221006100 cites W2551492803 @default.
• W4221006100 cites W2618596952 @default.
• W4221006100 cites W2633550421 @default.
• W4221006100 cites W2769724041 @default.
• W4221006100 cites W2784163112 @default.
• W4221006100 cites W2792403667 @default.
• W4221006100 cites W2794583203 @default.
• W4221006100 cites W2809314526 @default.
• W4221006100 cites W2901869599 @default.
• W4221006100 cites W2947247420 @default.
• W4221006100 cites W2949055219 @default.
• W4221006100 cites W2962862085 @default.
• W4221006100 cites W2970892087 @default.
• W4221006100 cites W2974314845 @default.
• W4221006100 cites W2991144521 @default.
• W4221006100 cites W3033768524 @default.
• W4221006100 cites W3038421127 @default.
• W4221006100 cites W3061398623 @default.
• W4221006100 cites W3092849554 @default.
• W4221006100 cites W3096611556 @default.
• W4221006100 cites W3097283770 @default.
• W4221006100 cites W3105501294 @default.
• W4221006100 cites W3107747907 @default.
• W4221006100 cites W3111105858 @default.
• W4221006100 cites W3120983281 @default.
• W4221006100 cites W3193383945 @default.
• W4221006100 cites W4211090737 @default.
• W4221006100 cites W4256745958 @default.
• W4221006100 doi "https://doi.org/10.1080/03007995.2022.2057152" @default.
• W4221006100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35350937" @default.
• W4221006100 hasPublicationYear "2022" @default.
• W4221006100 type Work @default.
• W4221006100 citedByCount "0" @default.
• W4221006100 crossrefType "journal-article" @default.
• W4221006100 hasAuthorship W4221006100A5012905064 @default.
• W4221006100 hasAuthorship W4221006100A5019197879 @default.
• W4221006100 hasAuthorship W4221006100A5039298409 @default.
• W4221006100 hasAuthorship W4221006100A5054051543 @default.
• W4221006100 hasAuthorship W4221006100A5089812265 @default.
• W4221006100 hasBestOaLocation W42210061001 @default.
• W4221006100 hasConcept C126322002 @default.
• W4221006100 hasConcept C137403100 @default.
• W4221006100 hasConcept C142724271 @default.
• W4221006100 hasConcept C144024400 @default.
• W4221006100 hasConcept C149923435 @default.
• W4221006100 hasConcept C19165224 @default.
• W4221006100 hasConcept C197934379 @default.
• W4221006100 hasConcept C204787440 @default.
• W4221006100 hasConcept C27081682 @default.
• W4221006100 hasConcept C2778375690 @default.
• W4221006100 hasConcept C2778541695 @default.
• W4221006100 hasConcept C67761136 @default.
• W4221006100 hasConcept C71924100 @default.
• W4221006100 hasConceptScore W4221006100C126322002 @default.
• W4221006100 hasConceptScore W4221006100C137403100 @default.
• W4221006100 hasConceptScore W4221006100C142724271 @default.
• W4221006100 hasConceptScore W4221006100C144024400 @default.
• W4221006100 hasConceptScore W4221006100C149923435 @default.
• W4221006100 hasConceptScore W4221006100C19165224 @default.
• W4221006100 hasConceptScore W4221006100C197934379 @default.
• W4221006100 hasConceptScore W4221006100C204787440 @default.
• W4221006100 hasConceptScore W4221006100C27081682 @default.
• W4221006100 hasConceptScore W4221006100C2778375690 @default.
• W4221006100 hasConceptScore W4221006100C2778541695 @default.
• W4221006100 hasConceptScore W4221006100C67761136 @default.
• W4221006100 hasConceptScore W4221006100C71924100 @default.
• W4221006100 hasFunder F4320307758 @default.
• W4221006100 hasIssue "5" @default.

• next